期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
立体定向放疗联合贝伐珠单抗及PD-1免疫治疗对非小细胞肺癌脑转移的疗效分析
1
作者 张喻洁 施汉飞 +1 位作者 茆勇 潘德键 《现代肿瘤医学》 CAS 2024年第16期3011-3018,共8页
目的:探讨立体定向放疗(stereotactic radiotherapy, SRT)联合贝伐珠单抗及程序性死亡受体1(programmed cell death-1,PD-1)免疫治疗方案在晚期非鳞非小细胞肺癌(non-squamous non-small cell lung cancer, ns-NSCLC)脑转移(brain metas... 目的:探讨立体定向放疗(stereotactic radiotherapy, SRT)联合贝伐珠单抗及程序性死亡受体1(programmed cell death-1,PD-1)免疫治疗方案在晚期非鳞非小细胞肺癌(non-squamous non-small cell lung cancer, ns-NSCLC)脑转移(brain metastases, BM)患者中的疗效和不良事件(adverse event, AE)。方法:回顾性收集中国人民解放军联勤保障部队第九〇四医院和江南大学附属医院于2019年5月至2021年12月收治的119例ns-NSCLC BM患者的临床资料,并继续随访。根据疗法分为3组:SP组:SRT+化疗;SBIP组:SRT+贝伐珠单抗+PD-1抑制剂免疫治疗+化疗;SBI组:SRT+贝伐珠单抗+PD-1抑制剂免疫治疗。比较各组的短期疗效、生存期及AE。进行亚组分析探索,并对试验进行危险因素分析。结果:SBIP组、SBI组在疾病控制率(disease control rate, DCR)、无进展生存期(progress-free survival, PFS)和总生存期(overall survival, OS)上差异无统计学意义,但均优于SP组,差异有统计学意义,SBI组在AE分级上与SBIP组有统计学差异,且AE发生率低于SBIP组。年龄、分化程度、治疗方案、体力状态(performance status, PS)评分、脑膜转移、程序性死亡受体配体1(programmed cell death-ligand 1,PD-L1)表达水平、确诊BM时肺原发灶直径为ns-NSCLC BM患者预后的独立危险因素。在亚组分析中,表皮生长因子受体(epidermal growth factor receptor, EGFR)阳性组与阴性组在OS上差异无统计学意义。结论:SRT联合贝伐珠单抗和免疫治疗能有效提升ns-NSCLC BM患者的疗效,且AE较少,安全性更高。 展开更多
关键词 非小细胞肺癌 脑转移 免疫检查点抑制剂 联合治疗 抗血管生成治疗 去化疗
下载PDF
复发上皮性卵巢癌治疗中值得关注的几个问题 被引量:6
2
作者 单莹 潘凌亚 《现代妇产科进展》 CSCD 北大核心 2020年第10期773-777,共5页
复发上皮性卵巢癌的治疗一直是妇科肿瘤领域关注和探讨的热点。根据患者对铂类化疗敏感性的不同,将复发上皮性卵巢癌分为铂敏感和铂耐药两大类。本文基于临床研究及指南推荐,分别针对复发上皮性卵巢癌治疗中需要重点关注的手术、化疗、... 复发上皮性卵巢癌的治疗一直是妇科肿瘤领域关注和探讨的热点。根据患者对铂类化疗敏感性的不同,将复发上皮性卵巢癌分为铂敏感和铂耐药两大类。本文基于临床研究及指南推荐,分别针对复发上皮性卵巢癌治疗中需要重点关注的手术、化疗、去化疗,以及如何规范地应用维持治疗问题进行阐述,探讨不同类型复发患者的治疗策略。 展开更多
关键词 复发上皮性卵巢癌 铂敏感 铂耐药 手术 化疗 去化疗 维持治疗
下载PDF
将至已至,未来可期——2019年肺癌免疫治疗年终盘点 被引量:1
3
作者 方文峰 张力 《肿瘤综合治疗电子杂志》 2020年第1期53-58,共6页
免疫治疗的蓬勃发展为驱动基因阴性的患者带来了希望,肺癌的治疗格局正在经历革命性变革。笔者通过梳理2019年肺癌免疫治疗的研究报道,总结为下述6方面。①长生存:驱动基因阴性的非小细胞肺癌患者接受免疫单药二线治疗的5年生存率约为1... 免疫治疗的蓬勃发展为驱动基因阴性的患者带来了希望,肺癌的治疗格局正在经历革命性变革。笔者通过梳理2019年肺癌免疫治疗的研究报道,总结为下述6方面。①长生存:驱动基因阴性的非小细胞肺癌患者接受免疫单药二线治疗的5年生存率约为15%,一线治疗的5年生存率为23.2%,其中高表达程序性死亡蛋白配体1(programmed death-ligand 1,PDL1)的患者5年生存率可达29.6%。②去化疗:帕博利珠单抗和阿特珠单抗为PD-L1高表达患者带来去化疗的机会,而纳武利尤单抗联合伊匹单抗为PD-L1阳性患者带来了去化疗的希望。③中国人群:KEYNOTE-042研究和KEYNOTE-407研究的中国人群数据证明了中国人群的疗效和安全性与全球数据一致,并且HR数值上优于全球数据。④中国研究:信迪利单抗和卡瑞利珠单抗等中国声音正在逐渐改变着中国肺癌患者的治疗格局。⑤早期拓展:免疫治疗向早期的拓展为更多患者争取治愈的希望。⑥精准化:PD-L1是目前唯一获批的伴随诊断标志物,肿瘤突变负荷的分析仍是“雾里看花”,如何更精准地筛选出优势人群是未来研究的方向。 展开更多
关键词 免疫治疗 长生存 去化疗 中国人群 中国研究 早期拓展 精准化
下载PDF
卵巢上皮癌复发后处理的研究进展
4
作者 李倩 李力 《现代妇产科进展》 CSCD 北大核心 2021年第5期381-385,共5页
卵巢癌早期症状无明显特异性,患者确诊时多为晚期,超过半数患者面临复发的风险,推迟复发时间已成为治疗的新突破口。目前,新兴靶向药物的维持治疗模式给复发性卵巢癌患者带来生存获益。现就卵巢上皮癌复发后最新治疗进展进行综述。
关键词 复发性卵巢癌 二次肿瘤细胞减灭术 靶向药物 维持治疗 去化疗模式
下载PDF
Histone Deacetylase Inhibition:An Important Mechanism in the Treatment of Lymphoma 被引量:1
5
作者 Shan-qi Guo Yi-zhuo Zhang 《Clinical oncology and cancer researeh》 CAS CSCD 2012年第2期85-89,共5页
Lymphomas enconlpass a group of malignancies that originate in the lymph nodes or other lymphoid tissues. Epigenetic modification, especially by histone deacetylase (HDACs), plays a key role during the occurrence an... Lymphomas enconlpass a group of malignancies that originate in the lymph nodes or other lymphoid tissues. Epigenetic modification, especially by histone deacetylase (HDACs), plays a key role during the occurrence and development of lymphomas. Consequently, HDAC inhibitors (HDACIs), a class of gene expression-modulating drugs, have emerged as promising mechanism-based agents for the treatment of lymphomas. This review presents the rationale of HDAC inhibition, describes the epigenetic-based mechanisms of action of HDACIs, discusses their clinical efficiency, and summarizes the current and future developments in this field. 展开更多
关键词 LYMPHOMA histone deacetylases THERAPEUTICS EPIGENOMICS
下载PDF
Clinical study on radiofrequency combined with ^(131)I therapy for dedifferentiated thyroid carcinomas
6
作者 Hengping Li Qinjiang Liu Feng Dong 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第5期274-277,共4页
Objective:The aim of this study was to explore clinical efficiency of radio frequency combined with 131I therapy for dedifferentiated thyroid carcinoma.Methods:All patients have been treated by radiofrequency connecte... Objective:The aim of this study was to explore clinical efficiency of radio frequency combined with 131I therapy for dedifferentiated thyroid carcinoma.Methods:All patients have been treated by radiofrequency connected with 131I in 29 cases of dedifferentiated thyroid carcinoma which performed radionuclide imaging and Ig array of blood serum before and after therapy,respectively.Results:There were 4(4/29) positive cases of radionuclide imaging before treatment and 19(19/29) cases 2 weeks after therapy,25(25/29) cases of overall efficacy and 15(15/29) curative cases. Conclusion: Radiofrequency connected with 131I improve clinical efficacy of 131I treatment for dedifferentiated thyroid cancer of thyroid in view of higher absorbing 131I of thyroid cancerous cell. 展开更多
关键词 carcinoma of thyroid RADIOFREQUENCY 131I treatment
下载PDF
Demethylation of FANCF gene may be a potential treatment through inhibiting the proliferation of cervical cancer
7
作者 Min Li Chanyu Zhang 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第7期339-342,共4页
Objective: The aim of the study was to explore the effect of demethylating agent 5-Aza-2'-deoxycytidine (5-ADC) on expression of Fanconi anemia complementation group F (FANCF) gene and the proliferation of cervica... Objective: The aim of the study was to explore the effect of demethylating agent 5-Aza-2'-deoxycytidine (5-ADC) on expression of Fanconi anemia complementation group F (FANCF) gene and the proliferation of cervical cancer cells, to observe cell's sensitivity to chemotherapeutic drug taxol, and to explore the antitumor effect of 5-ADC as well as the new treatment of cervical cancer. Methods: Cervical cancer cell lines SiHa (FANCF gene full-methylated) and Hela (unmethylated) were treated with 5-ADC. We used the methylation-specific PCR (MSP), reverse transcription-polymerase chain reaction (RT-PCR) and Western blot to detect the FANCF methylation, mRNA and protein respectively. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect the proliferation of cells. The cytotoxicity of taxol was measured by flow cytometer. The nude mice bearing SiHa was used to observe the effect of 5-ADC in vivo. Results: Inhibition of DNA promoter methylation by 5-ADC reactivated the expression of FANCF mRNA and protein in SiHa cells, consistent with decreased growth speed and increased taxol resistance. These results were proven in experiments in vivo. Conclusion: The 5-ADC probably become a potential treatment drug through inhibiting the proliferation of cervical cancer cells in taxol-resistant patients. 展开更多
关键词 Fanconi anemia complementation group F (FANCF) cervical cancer 5-Aza-2'-deoxycytidine (5-ADC) methyla-tion DEMETHYLATION
下载PDF
Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease 被引量:7
8
作者 Zi-Ying WANG Wen QIN Fan YI 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第2期153-164,共12页
Although the pathogenesis of cardio-cerebrovascular disease (CCVD) is multifactorial, an increasing number of experimental and clinical studies have highlighted the importance of histone deacetylase (HDAC)-mediate... Although the pathogenesis of cardio-cerebrovascular disease (CCVD) is multifactorial, an increasing number of experimental and clinical studies have highlighted the importance of histone deacetylase (HDAC)-mediated epigenetic processes in the development of cardio-cerebrovascular injury. HDACs are a family of enzymes to balance the acetylation activities of histone acetyltransferases on chromatin remodeling and play essential roles in regulating gene transcription. To date, 18 mammalian HDACs are identified and grouped into four classes based on similarity to yeast orthologs. The zinc-dependent HDAC family currently consists of 11 members divided into three classes (class I, II, and IV) on the basis of structure, sequence homology, and domain organization. In comparison, class III HDACs (also known as the sirtuins) are composed of a family of NAD+-dependent protein-modifying enzymes related to the Sir2 gene. HDAC inhibitors are a group of compounds that block HDAC activities typically by binding to the zinc-containing catalytic domain of HDACs and have displayed an- ti-inflammatory and antifibrotic effects in the cardio-cerebrovascular system. In this review, we summarize the current knowledge about classifications, functions of HDACs and their roles and regulatory mechanisms in the cardio-cerebrovascular system. Pharmacological tar- geting of HDAC-mediated epigenetic processes may open new therapeutic avenues for the treatment of CCVD. 展开更多
关键词 Histone deacetylase Epigenetic modification Heart failure ATHEROSCLEROSIS STROKE
下载PDF
Electrochemical treatment of COD in biologically pretreated coking wastewater using Ti/RuO2-IrO2 electrodes combined with modified coke 被引量:3
9
作者 HE Xu-wen LIU Li-yuan GONG Jing-wen WANG Jian-bing QIN Qiang WANG Hao 《Journal of Coal Science & Engineering(China)》 2011年第4期426-430,共5页
The electrochemical treatment of COD contained in biologically pretreated coking wastewater treated by a three-dimensional electrode system with modified coke as the particle electrode was investigated. And the electr... The electrochemical treatment of COD contained in biologically pretreated coking wastewater treated by a three-dimensional electrode system with modified coke as the particle electrode was investigated. And the electrochemical perromance of the coke modified with various active components was studied. The results show that the coke modified with Fe(NO3)2 has the lowest energy consumption and higher COD removal rate under the same condition, and the modified coke has better surface characteristics for the purpose of this study. In addition, the kinetic constant was also calculated. The study shows that the three-dimensional electrode system with Fe (NO3)z-modified coke can give a satisfactory solution in biologically pretreated coking wastewater. 展开更多
关键词 three-dimensional electrode Ti/RuO2-IrO2 anode Fe (NO3)2-modified coke coking wastewater
下载PDF
滤泡性淋巴瘤研究进展 被引量:6
10
作者 赵东陆 马军 《白血病.淋巴瘤》 CAS 2018年第1期16-19,共4页
滤泡性淋巴瘤(FL)起源于生发中心B细胞,是我国最常见的惰性B细胞非霍奇金淋巴瘤(NHL),目前仍是一种不可治愈的疾病。在第59届美国血液学会(ASH)年会上,FL为NHL领域报道最多的亚型。目前FL的研究热点为诱导后维持治疗、新药联... 滤泡性淋巴瘤(FL)起源于生发中心B细胞,是我国最常见的惰性B细胞非霍奇金淋巴瘤(NHL),目前仍是一种不可治愈的疾病。在第59届美国血液学会(ASH)年会上,FL为NHL领域报道最多的亚型。目前FL的研究热点为诱导后维持治疗、新药联合诱导治疗及维持治疗、去化疗治疗FL以及寻找新的预后生物学标志。 展开更多
关键词 淋巴瘤 滤泡型 维持治疗 去化疗
原文传递
急性早幼粒细胞白血病治疗方案的优化研究 被引量:4
11
作者 李森 王书杰 《中国实用内科杂志》 CAS CSCD 北大核心 2016年第4期329-331,共3页
急性早幼粒细胞白血病(APL)是急性髓系白血病的亚型之一。超过95%的APL患者15号染色体的PML基因与17号染色体的RARA基因发生融合形成PML-RARA融合基因,其产生的融合蛋白导致髓系细胞分化障碍并停滞住早幼粒细胞阶段。
关键词 急性早幼粒细胞 全反式维甲酸 三氧化二砷 去化疗
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部